DE50110829D1 - METHOD OF PREPARING 4- (17ALPHA-SUBSTITUTED-3-OXOESTRA-4,9-DIEN-11BETA-YL) BENZALDEHYDE (1E OR 1Z) -OXIMES - Google Patents

METHOD OF PREPARING 4- (17ALPHA-SUBSTITUTED-3-OXOESTRA-4,9-DIEN-11BETA-YL) BENZALDEHYDE (1E OR 1Z) -OXIMES

Info

Publication number
DE50110829D1
DE50110829D1 DE50110829T DE50110829T DE50110829D1 DE 50110829 D1 DE50110829 D1 DE 50110829D1 DE 50110829 T DE50110829 T DE 50110829T DE 50110829 T DE50110829 T DE 50110829T DE 50110829 D1 DE50110829 D1 DE 50110829D1
Authority
DE
Germany
Prior art keywords
sub
oxoestra
11beta
17alpha
dien
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE50110829T
Other languages
German (de)
Inventor
Gerd Schubert
Sven Ring
Bernd Erhart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to DE50110829T priority Critical patent/DE50110829D1/en
Application granted granted Critical
Publication of DE50110829D1 publication Critical patent/DE50110829D1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0085—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Studio Devices (AREA)

Abstract

The invention relates to a method for the production of 4-(17alpha substituted 3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1E or 1Z)-oximes of general formula (I), where R<SUB>1</SUB>-H, C<SUB>1-6 </SUB>alkyl or a C<SUB>n</SUB>F<SUB>2n+1 </SUB>group; R<SUB>2</SUB>-C<SUB>1-4 </SUB>alkyl, X=E- or Z-OH; and Y-O-C<SUB>1-6 </SUB>alkyl, S-C<SUB>1-6 </SUB>alkyl or O-CH<SUB>2</SUB>C<SUB>n</SUB>F<SUB>2n+1</SUB>, where n=1, 2 or 3, which produces the target compounds of formula (I) with high yield and selectivity.
DE50110829T 2000-11-10 2001-11-09 METHOD OF PREPARING 4- (17ALPHA-SUBSTITUTED-3-OXOESTRA-4,9-DIEN-11BETA-YL) BENZALDEHYDE (1E OR 1Z) -OXIMES Expired - Lifetime DE50110829D1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE50110829T DE50110829D1 (en) 2000-11-10 2001-11-09 METHOD OF PREPARING 4- (17ALPHA-SUBSTITUTED-3-OXOESTRA-4,9-DIEN-11BETA-YL) BENZALDEHYDE (1E OR 1Z) -OXIMES

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10056676A DE10056676A1 (en) 2000-11-10 2000-11-10 Preparation of estradienyl-benzaldoxime derivative preparation in high yield, for use e.g. in treating endometriosis, from epoxy-estrenone by multi-stage process including selective Grignard reaction
PCT/DE2001/004218 WO2002038582A2 (en) 2000-11-10 2001-11-09 Method for the production of 4-(17alpha substituted 3-oxoestra-4,9-dien-11-yl)benzaldehyd-(1e or 1z)-oximes
DE50110829T DE50110829D1 (en) 2000-11-10 2001-11-09 METHOD OF PREPARING 4- (17ALPHA-SUBSTITUTED-3-OXOESTRA-4,9-DIEN-11BETA-YL) BENZALDEHYDE (1E OR 1Z) -OXIMES

Publications (1)

Publication Number Publication Date
DE50110829D1 true DE50110829D1 (en) 2006-10-05

Family

ID=7663441

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10056676A Withdrawn DE10056676A1 (en) 2000-11-10 2000-11-10 Preparation of estradienyl-benzaldoxime derivative preparation in high yield, for use e.g. in treating endometriosis, from epoxy-estrenone by multi-stage process including selective Grignard reaction
DE50110829T Expired - Lifetime DE50110829D1 (en) 2000-11-10 2001-11-09 METHOD OF PREPARING 4- (17ALPHA-SUBSTITUTED-3-OXOESTRA-4,9-DIEN-11BETA-YL) BENZALDEHYDE (1E OR 1Z) -OXIMES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10056676A Withdrawn DE10056676A1 (en) 2000-11-10 2000-11-10 Preparation of estradienyl-benzaldoxime derivative preparation in high yield, for use e.g. in treating endometriosis, from epoxy-estrenone by multi-stage process including selective Grignard reaction

Country Status (26)

Country Link
US (1) US7214808B2 (en)
EP (1) EP1339734B1 (en)
JP (1) JP4263478B2 (en)
KR (1) KR100836323B1 (en)
CN (1) CN100368427C (en)
AT (1) ATE337328T1 (en)
AU (2) AU1691102A (en)
BG (1) BG107886A (en)
BR (1) BR0115249A (en)
CA (1) CA2427632C (en)
CZ (1) CZ301425B6 (en)
DE (2) DE10056676A1 (en)
EA (1) EA005530B1 (en)
EE (1) EE200300222A (en)
HK (1) HK1063187A1 (en)
HR (1) HRP20030458A2 (en)
HU (1) HUP0301765A2 (en)
IL (2) IL155680A0 (en)
MX (1) MXPA03004109A (en)
NO (1) NO20032080L (en)
NZ (1) NZ525962A (en)
PL (1) PL205091B1 (en)
SK (1) SK286601B6 (en)
WO (1) WO2002038582A2 (en)
YU (1) YU34303A (en)
ZA (1) ZA200304480B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006018888A1 (en) * 2006-04-18 2007-10-25 Bayer Schering Pharma Ag Process for the preparation of 4- [17beta-methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-diene-11beta-yl] benzaldehyde (E) -oxime (asoprisnil)
JP4843372B2 (en) * 2006-05-09 2011-12-21 株式会社リコー Image processing device

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4332284C2 (en) * 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxime-17beta-methoxy-17alpha-methoxymethyl-estradiene derivatives, process for their preparation and medicaments containing these compounds
DE4332283A1 (en) * 1993-09-20 1995-04-13 Jenapharm Gmbh Novel 11-benzaldoximestradiene derivatives, processes for their preparation and medicaments containing these compounds
US5576310A (en) * 1994-09-20 1996-11-19 Jenapharm Gmbh 11-benzaldoxime-17β-methoxy-17α-methoxymethyl-estrasdiene derivatives, methods for their production and pharmaceuticals containing such compounds

Also Published As

Publication number Publication date
PL205091B1 (en) 2010-03-31
IL155680A0 (en) 2003-11-23
WO2002038582A3 (en) 2002-09-12
SK286601B6 (en) 2009-02-05
ZA200304480B (en) 2004-08-24
CZ301425B6 (en) 2010-02-24
EE200300222A (en) 2003-08-15
AU1691102A (en) 2002-05-21
NO20032080D0 (en) 2003-05-09
WO2002038582A2 (en) 2002-05-16
ATE337328T1 (en) 2006-09-15
HRP20030458A2 (en) 2005-04-30
EA200300506A1 (en) 2003-12-25
KR100836323B1 (en) 2008-06-09
US7214808B2 (en) 2007-05-08
NO20032080L (en) 2003-05-09
CA2427632A1 (en) 2003-05-01
JP2004513179A (en) 2004-04-30
SK5512003A3 (en) 2003-10-07
KR20030081330A (en) 2003-10-17
NZ525962A (en) 2005-02-25
EA005530B1 (en) 2005-04-28
CA2427632C (en) 2010-01-26
CN100368427C (en) 2008-02-13
BR0115249A (en) 2003-08-12
IL155680A (en) 2009-06-15
AU2002216911C1 (en) 2002-05-21
AU2002216911B2 (en) 2007-06-14
MXPA03004109A (en) 2004-07-08
CN1474829A (en) 2004-02-11
EP1339734B1 (en) 2006-08-23
HK1063187A1 (en) 2004-12-17
PL361399A1 (en) 2004-10-04
BG107886A (en) 2004-02-27
DE10056676A1 (en) 2002-05-16
YU34303A (en) 2006-08-17
EP1339734A2 (en) 2003-09-03
CZ20031282A3 (en) 2003-08-13
HUP0301765A2 (en) 2003-09-29
JP4263478B2 (en) 2009-05-13
US20040053905A1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
DE60103508D1 (en) PYRROLOPYRIMIDINONE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF
NO20023189D0 (en) Process for the preparation of tolterodine and analogs thereof, as well as intermediates prepared by the process
KR860007209A (en) Preparation of Trisubstituted Benzoic Acid Intermediates
DE60306667D1 (en) CEFDINIR SALTS AS INTERMEDIATE PRODUCTS
ATE370127T1 (en) PYRIMIDINIC AZYCLONEUCLEOSIDES, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF
ATE442363T1 (en) METHOD FOR PRODUCING PYRIDINE COMPOUNDS
DK1246812T3 (en) Process for the preparation of citalopram
WO2005058812A3 (en) Prostaglandin synthesis
ATE407127T1 (en) METHOD FOR PRODUCING BERAPROST AND SALTS THEREOF
DE50110829D1 (en) METHOD OF PREPARING 4- (17ALPHA-SUBSTITUTED-3-OXOESTRA-4,9-DIEN-11BETA-YL) BENZALDEHYDE (1E OR 1Z) -OXIMES
EA200100129A1 (en) METHOD OF OBTAINING HYDROXYMETHYLBYTHEBUTANE ACID
DE60105441D1 (en) METHOD FOR PRODUCING PANTOPRAZOLE AND INTERMEDIATE PRODUCTS OF THIS METHOD
ATE275149T1 (en) METHOD FOR PRODUCING TAXAND DERIVATIVES
DE60015563D1 (en) METHOD FOR PRODUCING BENZOPERHYDROISOINDOLS
NO330965B1 (en) Process for Preparation of Substituted Imidazole Derivatives, Intermediates Used in the Process, and Process for Preparation of Intermediate
HUP0401099A2 (en) Method for producing 4-haloalkyl nicotine nitriles
BR0012481A (en) Deacylation process for lipodepsipeptides
BR0205164A (en) Process for azeotropically purifying aqueous polymerizable organic material
DE50114228D1 (en) PROCESS FOR PREPARATION OF 4- (17ALPHA-METHYL SUBSTITUTED) 3-OXOESTRA-4,9-DIEN-11BETA-YL) BENZALDEHYDE (1E OR 1Z) -OXIMENES
ATE190979T1 (en) METHOD FOR PRODUCING AETHER-TYPE THIOPHOSPHOLIPIDES
ATE311382T1 (en) METHOD FOR PRODUCING 2-CARBAMOYL-PYRIDINES
BR0117363B1 (en) process for the preparation of a 2-cyanopyridine compound of general formula (ii)
ATE419229T1 (en) METHOD FOR PRODUCING MACROCYCLIC KETONES BY DIECKMANN CONDENSATION IN THE GAS PHASE
DE50102362D1 (en) METHOD FOR PRODUCING 4- (17-ALPHA-ALKOXYMETHYL-17-BETA-SUBSTITUTED-3-OXOESTRA-4,9-DIEN-11-BETA-YL) BENZALDEHYDE- (1E) -OXIME DERIVATIVES
HUP0300348A2 (en) Method for producing aryl-iminomethyl-carbamic acid esters

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: BAYER SCHERING PHARMA AG, 13353 BERLIN, DE

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BAYER SCHERING PHARMA AKIENGESELLSCHAFT, 13353, DE